Document:

Exhibit
4(a)

 

CONVERTIBLE
PROMISSORY NOTE

 

NEITHER
THIS NOTE, NOR THE COMMON STOCK THIS NOTE IS CONVERTIBLE INTO, HAS, AS OF THE ISSUANCE DATE, BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR
OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE
AND SCOPE REASONABLY SATISFACTORY TO THE COMPANY, THAT THIS NOTE MAY BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF, UNDER AN
EXEMPTION FROM REGISTRATION UNDER THE ACT AND SUCH STATE SECURITIES LAWS.

 

CANNABIS
GLOBAL, INC.

A
Nevada Corporation 

 

Convertible
Promissory Note

$30,000

 

Dated:
April 30, 2020 (“Issuance Date”)

 

 

For
value received, Cannabis Global, Inc., a Nevada corporation, (the “Company”), hereby promises to pay to Robert
L. Hymers, III (together with his respective successors, representatives, transferees and permitted assigns, (collectively,
the “Holder”), thirty thousand dollars ($30,000.00) (the “Principal Amount”). Annual interest of
ten percent (10%) accrues on the Principal Amount. Unless earlier converted into Conversion Shares (as defined below), the principal
of this Note will be due and payable by the Company at any time on or after December 31, 2020 (“Maturity Date”) at
the Company’s election or upon demand by the Holder.

 

All
payments under or pursuant to this Convertible Promissory Note refer to and shall be made in United States Dollars in immediately
available funds to the Holder at the address of the Holder first set forth below or at such other place as the Holder may designate
from time to time in writing to the Company or by wire transfer of funds to the Holder’s account.

 

 

 

RECITALS

 

The
Company is a corporation formed and operating in good standing under the laws of the State of Nevada. Company’s common stock
is listed on the OTC Markets listing service under the trading symbol “MCTC.” The Company is a reporting company under
the 1934 Securities and Exchange Act and as of the date of this Convertible Promissory Note, is current with its reporting obligations
thereunder. The Company has Common Stock, par value $0.001, 290,000,000 shares authorized, 15,093,126 shares issued and outstanding
at February 29, 2020. The Company enters into this Convertible Promissory Note as part of a settlement agreement with the Holder
dated April 30, 2020 (copy attached).

 

     

     

    

 

ARTICLE
I

 

PAYMENT

 

Section
1.1 Payment. All payments will be made in lawful money of the United States of America at Holder’s office located
at 520 S. Grand Avenue, Ste. 320, Los Angeles, CA 90071, or at such other place as the Holder may from time to time designate
in writing to the Company. Prepayment of the principal amount may not be made without the written consent of the Holder, except
in the event of a Corporate Transaction (as set forth in Section 3.2(d).

 

ARTICLE
II

 

SECURITY

 

 Section
2.1 Security. This Convertible Promissory Note is a general unsecured obligation of the Company.

 

ARTICLE
III

 

CONVERSION

 

Section
3.1 Conversion. This Convertible Promissory Note will be convertible into Equity Securities pursuant to the following
terms.

 

 Section
3.2 Definitions.

 

(a) “Common
Stock” means the Company’s common stock, par value US $0.001 per share.

 

(b) “Conversion
Shares,” for purposes of determining the type of Equity Securities issuable upon conversion of this Convertible Promissory
Note, means:

 

(i) with
respect to a conversion pursuant to Sections 3.2 or 3.4, (a) one million, five hundred thousand (1,500,000) shares of Common Stock;

 

(c) “Conversion
Price,” is fixed at two cents ($0.02) per share.

 

    Page 2 of 10

     

    

 

(d) “Corporate
Transaction” means:

 

(i) the
closing of the sale, transfer or other disposition, in a single transaction or series of related transactions, of all or substantially
all of the Company’s assets;

 

(ii) the
consummation of a merger or consolidation of the Company with or into another entity (except a merger or consolidation in which
the holders of capital stock of the Company immediately prior to such merger or consolidation continue to hold a majority of the
outstanding voting securities of the capital stock of the Company or the surviving or acquiring entity immediately following the
consummation of such transaction); or

 

(iii) the
closing of the transfer (whether by merger, consolidation or otherwise), in a single transaction or series of related transactions,
to a “person” or “group” (within the meaning of Section 13(d) and Section 14(d) of the Exchange Act), of the
Company’s capital stock if, after such closing, such person or group would become the “beneficial owner” (as defined
in Rule 13d-3 under the Exchange Act) of more than 50% of the outstanding voting securities of the Company (or the surviving or
acquiring entity).

 

For
the avoidance of doubt, a transaction will not constitute a “Corporate Transaction” if its sole purpose is to change
the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions
by the persons who held the Company’s securities immediately prior to such transaction. Notwithstanding the foregoing, the sale
of Equity Securities in a bona fide financing transaction will not be deemed a “Corporate Transaction.”

 

(e) “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

 Section
3.3 Corporate Transaction Conversion. In the event of a Corporate Transaction prior to the conversion of this Note pursuant
to Section 3.2 or the repayment of this Note, at the closing of such Corporate Transaction, the Holder may elect that either:
(a) the Company will pay the Holder an amount equal to the sum of the outstanding principal balance of this Note; or (b) this
Note will convert into that number of Conversion Shares equal to the quotient (rounded down to the nearest whole share) obtained
by dividing (x) the outstanding principal balance by (y) the applicable Conversion Price.

 

 Section
3.4 Pre-Maturity Conversion. At any time after the issuance date, at the election of the Holder, this Convertible Promissory
Note will convert into that number of one million, five hundred thousand (1,500,000) Conversion Shares.

 

(a)
Should the Company determine to register any of its common stock under the Securities and Exchange Act, it agrees to include Holder’s
Conversion Shares in any such registration statement.

 

 Section
3.5 Mechanics of Conversion. Holder shall deliver to Company a copy of this Note and a Notice of Election to Convert
in the form attached hereto as Exhibit B.

 

(a) Certificates.
As promptly as practicable after the conversion of this Note and the issuance of the Conversion Shares, the Company (at its expense)
will issue and deliver a certificate or certificates evidencing the Conversion Shares (if certificated) to the Holder, or if the
Conversion Shares are not certificated, will deliver a true and correct copy of the Company’s share register reflecting the Conversion
Shares held by the Holder. The Company will not be required to issue or deliver the Conversion Shares until the Holder has surrendered
this Note to the Company (or provided an instrument of cancellation or affidavit of loss).

 

    Page 3 of 10

     

    

 

 (b) Fractional
Shares. No fractional shares of Common Stock shall be issued upon conversion of this Note.

 

 (c) No
Impairment. The Company shall not, by amendment of its Certificate of Incorporation or through any reorganization, transfer
of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid
the observance or performance of any of the terms to be observed or performed hereunder by the Company under this Note, but will
at all times in good faith, assist in the carrying out of all the provisions of this Note, and in the taking of all such action
as may be necessary or appropriate in order to protect the Conversion Rights of the Holder against impairment.

 

 (d) Replacement.
Upon receipt of a duly executed, notarized and unsecured written statement from the Holder with respect to the loss, theft or
destruction of this Note (or any replacement hereof), and without requiring an indemnity bond or other security, or, in the case
of a mutilation of this Note, upon surrender and cancellation of such Note, the Company shall issue a new Note, of like tenor
and amount, in lieu of such lost, stolen, destroyed or mutilated Note.

 

(e) Reservation
of Common Stock. The Company shall at all times when this Note shall be outstanding, reserve and keep available out of its
authorized but unissued Common Stock, such number of shares of Common Stock as shall from time to time be sufficient to effect
the conversion of this Note.

 

 (f) The
Company shall, from time to time in accordance with Delaware corporate law, increase the authorized number of shares of Common
Stock if at any time the unissued number of authorized shares shall not be sufficient to satisfy the Company’s obligations
under this Note.

 

 (g) No
Rights as Shareholder. Nothing contained in this Note shall be construed as conferring upon the Holder, prior to the conversion
of this Note, the right to vote or to receive dividends or to consent or to receive notice as a shareholder in respect of any
meeting of shareholders for the election of directors of the Company or of any other matter, or any other rights as a shareholder
of the Company.

 

    Page 4 of 10

     

    

 

ARTICLE
IV

 

REPRESENTATIONS
OF THE COMPANY

 

Representations
and Warranties of the Company. In connection with the transactions contemplated by this Note, the Company hereby represents
and warrants to the Holder as follows:

 

 Section
4.1 Due Organization; Qualification and Good Standing. The Company is a corporation duly organized, validly existing
and in good standing under the laws of the State of Nevada and has all requisite corporate power and authority to carry on its
business as now conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in
which the failure to so qualify or to be in good standing would have a material adverse effect on the Company.

 

 Section
4.2 Authorization and Enforceability. Except for the authorization and issuance of the Conversion Shares, all corporate
action has been taken on the part of the Company and its officers, directors and stockholders necessary for the authorization,
execution and delivery of this Note. Except as may be limited by applicable bankruptcy, insolvency, reorganization or similar
laws relating to or affecting the enforcement of creditors’ rights, the Company has taken all corporate action required to make
all of the obligations of the Company reflected in the provisions of this Note valid and enforceable in accordance with its terms.

 

 Section
4.3 Company provided Holder with full access to all information about Company Holder requested and considered necessary or
appropriate to make an informed investment decision with respect to the Convertible Promissory Note, and the Conversion Shares
which may be acquired by Holder as a result of this Convertible Promissory Note, including reference to all SEC filings made by
Company and its audited financial statements and risk factors in its registration statement. Company further answered all questions
of Holder, and provided additional information necessary to verify any information furnished to Holder or to which Holder had
access.

 

ARTICLE
V

 

REPRESENTATIONS
OF THE HOLDER

 

Representations
and Warranties of the Holder. In connection with the transactions contemplated by this Note, the Holder hereby represents
and warrants to the Company as follows:

 

 Section
5.1 Authorization. The Holder has full power and authority (and, if an individual, the capacity) to enter into this
Note and to perform all obligations required to be performed by it hereunder. This Note, when executed and delivered by the Holder,
will constitute the Holder’s valid and legally binding obligation, enforceable in accordance with its terms, except (a) as limited
by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application
affecting enforcement of creditors’ rights generally, and (b) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies.

 

 Section
5.2 Purchase Entirely for Own Account. The Holder acknowledges that this Note is made with the Holder in reliance upon
the Holder’s representation to the Company, which the Holder hereby confirms by executing this Note, that this Note, the Conversion
Shares, and any Common Stock issuable upon conversion of the Conversion Shares (collectively, the “Securities”) will
be acquired for investment for the Holder’s own account, not as a nominee or agent (unless otherwise specified on the Holder’s
signature page hereto), and not with a view to the resale or distribution of any part thereof, and that the Holder has no present
intention of selling, granting any participation in, or otherwise distributing the same. By executing this Note, the Holder further
represents that the Holder does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer
or grant participations to such person or to any third person, with respect to the Securities. If other than an individual, the
Holder also represents it has not been organized solely for the purpose of acquiring the Securities.

 

    Page 5 of 10

     

    

 

  Section
5.3 Disclosure of Information; Non-Reliance. The Holder acknowledges that he has received all the information he considers
necessary or appropriate to enable him to make an informed decision concerning an investment in the Securities. The Holder further
represents that he has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions
of the offering of the Securities. The Holder confirms that the Company has not given any guarantee or representation as to the
potential success, return, effect or benefit (either legal, regulatory, tax, financial, accounting or otherwise) of an investment
in the Securities. In deciding to purchase the Securities, the Holder is not relying on the advice or recommendations of the Company
and has made his own independent decision that the investment in the Securities is suitable and appropriate for the Holder. The
Holder understands that no federal or state agency has passed upon the merits or risks of an investment in the Securities or made
any finding or determination concerning the fairness or advisability of this investment.

 

 Section
5.4 Investment Experience. The Holder is an investor in securities of companies in the development stage and acknowledges
that he is able to fend for himself, can bear the economic risk of his investment and has such knowledge and experience in financial
or business matters that he is capable of evaluating the merits and risks of the investment in the Securities.

 

 Section
5.5 Accredited Investor. The Holder is an “accredited investor” within the meaning of Rule 501 of Regulation
D promulgated under the Securities Act. The Holder agrees to furnish any additional information requested by the Company or any
of its affiliates to assure compliance with applicable U.S. federal and state securities laws in connection with the purchase
and sale of the Securities.

 

 Section
5.6 Restricted Securities. Holder understands that he will receive “restricted securities” under U.S. federal
and applicable state securities laws and that, pursuant to these laws, the Holder must hold the Securities indefinitely unless
and until they are registered with the SEC and registered or qualified by state authorities, or an exemption from such registration
and qualification requirements is available. The Holder acknowledges that whether an exemption from registration or qualification
is available, may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding
period for the Securities, and on requirements relating to the Company which are outside of the Holder’s control, and which the
Company is under no obligation, and may not be able, to satisfy.

 

    Page 6 of 10

     

    

 

(a) No
Public Market. The Holder understands that no public market now exists for the Securities and that the Company has made no
assurances that a public market will ever exist for the Securities.

 

(b) No
General Solicitation. The Holder has not either directly or indirectly, including through a broker or finder, solicited offers
for or offered or sold the Securities by means of any form of general solicitation or general advertising within the meaning of
Rule 502 of Regulation D under the Securities Act or in any manner involving a public offering within the meaning of Section 4(a)(2)
of the Securities Act. The Holder acknowledges that neither the Company nor any other person offered to sell the Securities to
it by means of any form of general solicitation or advertising within the meaning of Rule 502 of Regulation D under the Securities
Act or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act.

 

(c) Investment
Experience. Holder understands that his acquisition of the Securities involves substantial risk. Holder has experience as
an investor in securities of private companies and companies in the development stage and acknowledges that Holder is able to
fend for himself, can bear the economic risk of his investment in the Securities and has such knowledge and experience in financial
or business matters that Holder is capable of evaluating the merits and risks of this investment in the Securities and protecting
his own interests in connection with this investment.

 

(d) Compliance
with Laws. Without in any way limiting the representations set forth above, Holder further agrees not to make any disposition
of all or any portion of the Securities, except in compliance with applicable securities laws.

 

(e) Legend.
It is understood that the certificates evidencing the shares of restricted securities will bear a legend substantially in the
form set forth below.

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR
UNDER THE SECURITIES LAWS OF ANY OTHER JURISDICTION. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE
AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION
OR EXEMPTION THEREFROM. PURCHASERS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR
AN INDEFINITE PERIOD OF TIME.

 

(f) Disclosure
of Information. Holder has received or has had full access to all the information Holder considers necessary or appropriate
to make an informed investment decision with respect to the Securities to be acquired by Holder as a result of this Note. Holder
further has had an opportunity to ask questions of and receive answers from the management of Company regarding the Securities,
and to obtain additional information necessary to verify any information furnished to Holder or to which Holder had access. Further,
Holder has undertaken its own review of the business of Company and the wisdom of an investment in the Company Securities. Holder
has had the opportunity to review all of the books, records and all SEC filings of Company, including all Company audited financial
statements, financial disclosures and risk factors that Company has published concerning its operations. Holder acknowledges being
knowledgeable about companies in the development stage, and the risk factors associated with such companies.

 

    Page 7 of 10

     

    

 

ARTICLE
VI

 

MISCELLANEOUS

 

 Section
6.1 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Note will inure to
the benefit of, and be binding upon, the respective successors and assigns of the parties; provided, however, that the Company
may not assign its obligations under this Note without the written consent of the Holder. This Note is for the sole benefit of
the parties hereto and their respective successors and permitted assigns, and nothing herein, express or implied, is intended
to or will confer upon any other person or entity any legal or equitable right, benefit or remedy of any nature whatsoever under
or by reason of this Note.

 

 Section
6.2 Choice of Law. This Note, and all matters arising out of or relating to this Note, whether sounding in contract,
tort, or statute will be governed by and construed in accordance with the internal laws of the State of California, without giving
effect to the conflict of laws provisions thereof to the extent such principles or rules would require or permit the application
of the laws of any jurisdiction other than those of the State of California.

 

 Section
6.3 Counterparts. This Note may be executed in counterparts, each of which will be deemed an original, but all of which
together will be deemed to be one and the same agreement. Counterparts may be delivered via facsimile, electronic mail (including
PDF or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission
method, and any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and effective for
all purposes.

 

 Section
6.4 Titles and Subtitles. The titles and subtitles used in this Note are included for convenience only and are not to
be considered in construing or interpreting this Note.

 

 Section
6.5 Notices. All notices and other communications given or made pursuant hereto will be in writing and will be deemed
effectively given: (a) upon personal delivery to the party to be notified; (b) when sent by email or confirmed facsimile; (c)
five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one (1)
day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt.
All communications will be sent to the respective parties at the addresses shown on the signature pages hereto (or to such email
address, facsimile number or other address as subsequently modified by written notice given in accordance with this Section 6.5).

 

 Section
6.6 No Finder’s Fee. Each party represents that it neither is nor will be obligated to pay any finder’s fee, broker’s
fee or commission in connection with the transactions contemplated by this Note. The Holder agrees to indemnify and to hold the
Company harmless from any liability for any commission or compensation in the nature of a finder’s or broker’s fee arising out
of the transactions contemplated by this Note (and the costs and expenses of defending against such liability or asserted liability)
for which the Holder or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and
hold the Holder harmless from any liability for any commission or compensation in the nature of a finder’s or broker’s fee arising
out of the transactions contemplated by this Note (and the costs and expenses of defending against such liability or asserted
liability) for which the Company or any of its officers, employees or representatives is responsible.

 

    Page 8 of 10

     

    

 

 Section
6.7 Attorneys’ Fees. If any action at law or in equity is necessary to enforce or interpret the terms of this Note,
the prevailing party will be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other
relief to which such party may be entitled.

 

 Section
6.8 Entire Agreement; Amendments and Waivers. This Note constitutes the full and entire understanding and agreement
between the parties with regard to the subject hereof. Any term of this Note may be amended and the observance of any term may
be waived (either generally or in a particular instance and either retroactively or prospectively) with the written consent of
the Company and the Holder. Any waiver or amendment effected in accordance with this Section 6.8 will be binding upon each future
holder of this Note and the Company.

 

 Section
6.9 Severability. If one or more provisions of this Note are held to be unenforceable under applicable law, such provisions
will be excluded from this Note and the balance of the Note will be interpreted as if such provisions were so excluded and this
Note will be enforceable in accordance with its terms.

 

 Section
6.10 Acknowledgment. For the avoidance of doubt, it is acknowledged that the Holder will be entitled to the benefit
of all adjustments in the number of shares of the Company’s capital stock as a result of any splits, recapitalizations, combinations
or other similar transactions affecting the Company’s capital stock underlying the Conversion Shares that occur prior to the conversion
of this Note.

 

 Section
6.11 Further Assurances. From time to time, the parties will execute and deliver such additional documents and will
provide such additional information as may reasonably be required to carry out the terms of this Note and any agreements executed
in connection herewith.

 

 Section
6.12 Officers and Directors not Liable. In no event will any officer or director of the Company be liable for any amounts
due and payable pursuant to this Note.

 

 Section
6.13 Approval. The Company hereby represents that its board of directors, in the exercise of its fiduciary duty, has
approved the Company’s execution of this Note based upon a reasonable belief that the principal provided hereunder is appropriate
for the Company after reasonable inquiry concerning the Company’s financing objectives and financial situation. In addition, the
Company hereby represents that it intends to use the principal of this Note primarily for the operations of its business, and
not for any personal, family or household purpose.

 

    Page 9 of 10

     

    

 

 Section
6.14 Waiver of Jury Trial. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED
UPON OR ARISING OUT OF THIS NOTE, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED
TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION,
INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON
LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE
SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER REPRESENTS AND WARRANTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH
ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL
COUNSEL.

 

	 	Dated:
    April 30, 2020
	 	 	 
	 	ROBERT
    L. HYMERS, III [HOLDER]
	 	 	 
	 	By:	
	 	 	ROBERT
    HYMERS
	 	 	520
    S. Grand Avenue, Ste. 320
	 	 	Los
    Angeles, CA 90071
	 	 	310-926-3980
	 	 	roberthymers@yahoo.com

 

	 	CANNABIS
    GLOBAL, INC.
	 	 	 
	 	By:	
	 	 	ARMAN TABATABAEI
	 	 	President, Chief
    Executive Officer
	 	 	520 S. Grand Avenue,
    Ste. 320
	 	 	Los Angeles, CA
    90071 
	 	 	Email: arman@cannabisglobalinc.com
	 	 	310-986-4929

 

 

Page 10  of 10Exhibit 10.1

 

Executive Employment Agreement 

 

This Executive Employment Agreement (the
“Agreement”) entered into as of June 17, 2019 (the “Effective Date”), by and between Arman Tabatabaei,
and individual (the “Executive”) and MCTC Holdings and or Cannabis Global Inc ., a corporation formed and operating
under the laws of the State of Delaware (the “Company”).

 

WHEREAS, the Company desires to
employ the Executive on the terms and conditions set forth herein;

 

WHEREAS, the Executive desires to
be employed by the Company on such terms and conditions.

 

NOW, THEREFORE, in consideration
of the mutual covenants, promises, and obligations set forth herein, the parties agree as follows:

 

		1.	Term. The Executive’s employment hereunder shall
be effective as of June 1, 2019 (the “Effective Date”) and shall continue from year to year until unless terminated
earlier pursuant to Section 5 of this Agreement. The period during which the Executive is employed by the Company hereunder is
hereinafter referred to as the “Employment Term.”

 

		2.	Position
and Duties.

 

		2.1	Position. During the Employment Term, the Executive
shall serve as the Chief Executive Officer, Chief Financial Officer, Secretary and Chairman of the Board of Directors of the Company,
reporting to the Board of Directors. In such position, the Executive shall have such duties, authority, and responsibility as
shall be determined from time to time by the Board of Directors, which duties, authority, and responsibility are consistent with
the Executive’s position.

 

		2.2	Duties.
During the Employment Term, the Executive shall devote substantially all of his business time and attention to the performance
of the Executive’s duties hereunder and will not engage in any other business, profession, or occupation for compensation
or otherwise which would materially conflict or substantially interfere with the performance of such services either directly
or indirectly. The Company acknowledges that Executive is currently the consultant of Cannabis Strategic Ventures (OTCQB: NUGS)
and Sugarmade Inc (OTCQB: SGMD).

 

Notwithstanding the foregoing, the Executive
will be permitted to act or serve as consultant of NUGS and Sugarmade as long as these duties do not substantially interfere with
the material performance of the Executive’s duties and substantial responsibilities to the Company.

 

		3.	Place
of Performance. The principal place of Executive’s employment shall be the Company’s future principal executive office
located in Los Angeles, California metropolitan area, or such other place as may be determined by the Company in consultation
with the Executive. The Executive acknowledges that he may be required to travel on Company business during the Employment Term.

 

    1

     

    

  

		4.	Compensation.

 

		4.1	Base
Salary. The Company shall pay the Executive an annual rate of base salary of Sixty thousand dollars ($60,000.00) in monthly installments
of five thousand dollars ($5000.00) per month plus an accrued monthly compensation of ten thousand dollars ($10,000.00) per month
in accordance with the Company’s customary payroll practices and applicable wage payment laws. The Executive’s base
salary shall be reviewed at least annually by the Board and the Board may, but shall not be required to, increase the base salary
during the Employment Term.

 

The Executive’s annual base salary,
as in effect from time to time, is hereinafter referred to as “Base Salary.” In lieu of the payment of the Executive’s
Base Salary, the Executive is hereby granted the option to convert any or all unpaid Base Salary due and owing into common stock
of the Company at any time by providing a written notice to the Board.

 

		4.2	Annual
Bonus.

 

		(a)	For
each fiscal year of the Employment Term, the Executive shall be eligible to receive an annual bonus (the “Annual Bonus”).
However, the decision to provide any Annual Bonus and the amount and terms of any Annual Bonus shall be in the sole and absolute
discretion of the Board.

 

		(b)	The
Annual Bonus, if any, will be paid at a time in the discretion of the Board.

 

		(c)	Except
as otherwise provided in Section 5, in order to be eligible to receive an Annual Bonus, the Executive must be employed by the
Company on the last day of the applicable fiscal year end that Annual Bonuses are paid.

 

		4.3	Equity Award Targets. The Board has established at
three (3) year equity ownership target for Executive of eight-teen percent (18%) with an established initial award and two future
awards the amounts of which will b e determined by the Board on the first and second anniversaries to the Effective Date.

 

As follows:

 

Initial Equity Award. Executive will receive
an initial irrevocable equity award of Twelve Million (12,000,000) shares of the total outstanding common shares based on capital
table. The Equity Award common shares will be considered fully vested, earned and owned as of the Effective Date.

 

First Anniversary Award Target. The Board
of Directors has established, as if the Effective Date, a target additional equity award for Executive of an additional six and
a half percent (6.5%) of total equity for the Executive for his second year of employment with the Company. This is non-binding
on the Company and/or the Board.

 

Second Anniversary Award Target. The Board
of Directors has established, as of the Effective Date, a target additional equity award for Executive of an additional three and
a half percent (3.5%) of total equity for the Executive for his third year of employment with the Company. This is non-binding
on the Company and/or the Board.

 

		4.4	During the Employment Term, the Executive shall be
eligible to participate in the MCTC Holdings / Cannabis Global, Inc. Equity Incentive Plan or any successor plan (the “Plan”),
subject to the terms of the Plan, as determined by the Board or the Compensation Committee, in its discretion from time to time.

 

    2

     

    

  

		4.4	Fringe Benefits and Perquisites. During the Employment
Term, the Executive shall be entitled to fringe benefits and perquisites consistent with the practices of the Company, and to
the extent the Company provides similar benefits or perquisites (or both) to similarly situated executives of the Company during
the Employment Term, the Company shall provide the Executive with the same fringe benefits and perquisites.

 

		4.5	Employee Benefits. During the Employment Term, the
Executive shall be entitled to participate in all employee benefit plans, practices, and programs maintained by the Company, as
in effect from time to time (collectively, “Employee Benefit Plans,” on a basis which is no less favorable than is
provided to other similarly situated executives of the Company, to the extent consistent with applicable law and the terms of
the applicable Employee Benefit Plans. The Company reserves the right to amend or cancel any Employee Benefit Plans at any time
in its sole discretion, subject to the terms of such Employee Benefit Plan and applicable law.

 

		4.6	Vacation; Paid Time-Off. During the Employment Term,
the Executive shall be entitled to fifteen (15) paid vacation days per calendar year (prorated for partial years) in accordance
with the Company’s vacation policies, as in effect from time to time that is at least as favorable as that provided to other
similarly situated executives of the Company. The Executive shall receive other paid time-off in accordance with the Company’s
policies for executive officers as such policies may exist from time to time.

 

		4.7	Business Expenses. The Executive shall be entitled
to reimbursement for all reasonable and necessary out-of-pocket business, entertainment, and travel expenses incurred by the Executive
in connection with the performance of the Executive’s duties hereunder in accordance with the Company’s expense reimbursement
policies and procedures.

 

		4.8	Indemnification.

 

		(a)	In the event that the Executive is made a party or
threatened to be made a party to anyaction, suit, or proceeding, whether civil, criminal, administrative, or investigative (a
“Proceeding”), other than any Proceeding initiated by the Executive or the Company related to any contest or dispute
between the Executive and the Company or any of its affiliates with respect to this Agreement or the Executive’s employment
hereunder, by reason of the fact that the Executive is or was a director or officer of the Company, or any affiliate of the Company,
or is or was serving at the request of the Company as a director, officer, member, employee, or agent of another corporation or
a partnership, joint venture, trust, or other enterprise, the Executive shall be indemnified and held harmless by the Company
to the fullest extent applicable to any other officer or director of the Company to the maximum extent permitted under applicable
law and the Company’s bylaws from and against any liabilities, costs, claims, and expenses, including all costs and expenses
incurred in defense of any Proceeding (including attorneys’ fees). Costs and expenses incurred by the Executive in defense
of such Proceeding (including attorneys’ fees) shall be paid by the Company in advance of the final disposition of such
litigation upon receipt by the Company of: (i) a written request for payment; (ii) appropriate documentation evidencing the incurrence,
amount, and nature of the costs and expenses for which payment is being sought; and (iii) an undertaking adequate under applicable
law made by or on behalf of the Executive to repay the amounts so paid if it shall ultimately be determined that the Executive
is not entitled to be indemnified by the Company under this Agreement.

 

		(b)	During
the Employment Term and for a period of six (6) years thereafter, the Company or any successor to the Company shall purchase and
maintain, at its own expense, directors’ and officers’ liability insurance providing coverage to the Executive on
terms that are no less favorable than the coverage provided to other directors and similarly situated executives of the Company.

 

    3

     

    

  

		4.9	Clawback Provisions. Notwithstanding any other provisions
in this Agreement to the contrary, any incentive-based compensation, or any other compensation, paid to the Executive pursuant
to this Agreement or any other agreement or arrangement with the Company which is subject to recovery under any law, government
regulation. or stock exchange listing requirement, will be subject to such deductions and clawback as may be required to be made
pursuant to such law, government regulation, or stock exchange listing requirement (or any policy adopted by the Company pursuant
to any such law, government regulation or stock exchange listing requirement).

 

		5.	Termination of Employment. The Employment Term and the
Executive’s employment hereunder may be terminated by either the Company or the Executive at any time and for any reason;
provided that, unless otherwise provided herein, either party shall be required to give the other party at least thirty (30) days
advance written notice of any termination of the Executive’s employment. Upon termination of the Executive’s employment
during the Employment Term, the Executive shall be entitled to the compensation and benefits described in this Section 5 and shall
have no further rights to any compensation or any other benefits from the Company or any of its affiliates.

 

		5.1	By the Company For Cause or by the Executive Without
Good Reason.

 

		(a)	The Executive’s employment hereunder may be terminated
by the Company for Cause; or, by the Executive without Good Reason. If the Executive’s employment is terminated by the Company
for Cause or by the Executive without Good Reason, the Executive shall be entitled to receive:

 

		(i)	any
accrued but unpaid Base Salary and accrued but unused vacation which shall be paid on the pay date immediately following the Termination
Date (as defined below) in accordance with the Company’s customary payroll procedures;

 

		(ii)	any
earned but unpaid Annual Bonus with respect to any completed fiscal year immediately preceding the Termination Date, which shall
be paid on the otherwise applicable payment date, except to the extent payment is otherwise deferred pursuant to any applicable
deferred compensation arrangement; provided that, if the Executive’s employment is terminated by the Company for Cause,
then any such accrued but unpaid Annual Bonus shall be forfeited;

 

		(iii)	reimbursement
for unreimbursed business expenses properly incurred by the Executive, which shall be subject to and paid in accordance with the
Company’s expense reimbursement policy; and

 

		(iv)	such
employee benefits (including equity compensation), if any, to which the Executive may be entitled under the Company’s employee
benefit plans pro rata as of the Termination Date; provided that, in no event shall the Executive be entitled to any payments
in the nature of severance or termination payments except as specifically provided herein.

 

Items 5.1(a)(i) through 5.1(a)(iv) are
referred to herein collectively as the “Accrued Amounts”. (b) For purposes of this Agreement, “Cause” shall
mean:

 

		(i)	the
Executive’s willful failure to perform his duties, other than any such failure resulting from incapacity due to physical
or mental illness;

 

		(ii)	the
Executive’s willful failure to comply with any valid and legal directive of The Board of Directors;

 

		(iii)	the
Executive’s willful engagement in dishonesty, illegal conduct, or gross misconduct, which is, in each case, materially injurious
to the Company or its affiliates;

 

    4

     

    

  

		(iv)	the
Executive’s embezzlement, misappropriation, or fraud, whether or not related to the Executive’s employment with the
Company;

 

		(v)	the
Executive’s conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent)
or a crime that constitutes a misdemeanor involving moral turpitude, if such felony or other crime is work-related, materially
impairs the Executive’s ability to perform services for the Company or results in material, reputational or financial harm
to the Company or its affiliates;

 

		(vi)	the
Executive’s violation of a material policy of the Company;

 

		(vii)	the
Executive’s willful unauthorized disclosure of Confidential Information (as defined below);

 

		(viii)	the
Executive’s material breach of any material obligation under this Agreement or any other written agreement between
the Executive and the Company; or

 

		(ix)	any
material failure by the Executive to comply with the Company’s written policies or rules, as they may be in effect from
time to time during the Employment Term, if such failure causes material, reputational or financial harm to the Company.

 

For purposes of this provision, no act
or failure to act on the part of the Executive shall be considered “willful” unless it is done, or omitted to be done,
by the Executive in bad faith or without reasonable belief that the Executive’s action or omission was in the best interests
of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon
the advice of counsel for the Company or by virtue of an instruction or direction from The Board of Directors, shall be conclusively
presumed to be done, or omitted to be done, by the Executive in good faith and in the best interests of the Company.

 

Termination of the Executive’s employment
shall not be deemed to be for Cause unless and until the Company delivers to the Executive a copy of a resolution duly adopted
by the affirmative vote of not less than a majority of the Board (after reasonable written notice is provided to the Executive
and the Executive is given an opportunity, together with counsel, to be heard before the Board), finding that the Executive has
engaged in the conduct described in any of (i)-(ix) above. Except for a failure, breach, or refusal which, by its nature, cannot
reasonably be expected to be cured, the Executive shall have ten (10) business days from the delivery of written notice by the
Company within which to cure any acts constituting Cause; provided however, that, if the Company reasonably expects irreparable
injury from a delay of ten (10) business days, the Company may give the Executive notice of such shorter period within which to
cure as is reasonable under the circumstances, which may include the termination of the Executive’s employment without notice
and with immediate effect. The Company may place the Executive on paid leave for up to sixty (60) days while it is determining
whether there is a basis to terminate the Executive’s employment for Cause. Any such action by the Company will not constitute
Good Reason.

 

		(c)	For purposes of this Agreement, “Good Reason”
shall mean the occurrence of any of the following, in each case during the Employment Term without the Executive’s written
consent:

 

		(i)	a
material reduction in the Executive’s Base Salary other than a general reduction in Base Salary that affects all similarly
situated executives in substantially the same proportions;

 

		(ii)	a
material reduction in the Executive’s Target Bonus opportunity;

 

		(iii)	a
relocation of the Executive’s principal place of employment by more than fifty (50) miles;

 

		(iv)	any
material breach by the Company of any material provision of this Agreement, or any material provision of any other agreement between
the Executive and the Company;

 

    5

     

    

  

		(v)	the
Company’s failure to obtain an agreement from any successor to the Company to assume and agree to perform this Agreement
in the same manner and to the same extent that the Company would be required to perform if no succession had taken place, except
where such assumption occurs by operation of law;

 

		(vi)	a
material, adverse change in the Executive’s title, authority, duties, or responsibilities (other than temporarily while
the Executive is physically or mentally incapacitated or as required by applicable law) taking into account the Company’s
size, status as a public company, and capitalization as of the date of this Agreement; or,

 

		(vii)	a
material adverse change in the reporting structure applicable to the Executive.

 

The Executive cannot terminate his employment
for Good Reason unless he has provided written notice to the Company of the existence of the circumstances providing grounds for
termination for Good Reason within thirty [30] days of the initial existence of such grounds and the Company has had at least ten
[10] days from the date on which such notice is provided to cure such circumstances. If the Executive does not terminate his employment
for Good Reason within thirty [30] days after the first occurrence of the applicable grounds, then the Executive will be deemed
to have waived his right to terminate for Good Reason with respect to such grounds.

 

		5.2	Non-Renewal by the Company, Without Cause or for Good
Reason. The Employment Term and the Executive’s employment hereunder may be terminated on account of the Company’s
failure to renew the Agreement in accordance with Sections 1 and 5; by the Executive for Good Reason; or, by the Company without
Cause. In the event of such termination, the Executive shall be entitled to receive the Accrued Amounts and, subject to the Executive’s
compliance with Section 6, Section 7, Section 8, and Section 9 of this Agreement, and his execution of a release of claims in
favor of the Company, its affiliates and their respective officers and directors in a form provided by the Company (the “Release”)
and such Release becoming effective within thirty (30) days following the Termination Date (such 30- day period, the “Release
Execution Period”), the Executive shall be entitled to receive the following:

 

		(a)	a
lump sum payment equal to one (1) year of the Executive’s Base Salary and Target Bonus for the year in which the Termination
Date occurs, which shall be paid within thirty (30) days following the Termination Date; provided that, if the Release Execution
Period begins in one taxable year and ends in another taxable year, payment shall not be made until the beginning of the second
taxable year;

 

		(b)	The
treatment of any outstanding equity awards shall be determined in accordance with terms set by the Board or the Compensation Committee
of the Cannabis Global, Inc. Equity Incentive Plan or any successor Plan, and the applicable award agreements.

 

		(c)	Notwithstanding
the terms of the Cannabis Global, Inc. Equity Incentive Plan or any successor Plan or any applicable award agreements:

 

		1.	all
outstanding unvested stock options and/or stock appreciation rights granted to the Executive during the Employment Term shall
become fully vested and exercisable for the remainder of their full term;

 

		2.	all
outstanding equity-based compensation awards, other than stock options or stock appreciation rights, that are not intended to
qualify as performance-based compensation under Section 162(m)(4)(C) of the Internal Revenue Code of 1986, as amended (the “Code”),
shall become fully vested and the restrictions thereon shall lapse; provided that, any delays in the settlement or payment of
such awards that are set forth in the applicable award agreement and that are required under Section 409A of the Code (“Section
409A”) shall remain in effect; and,

 

    6

     

    

  

		3.	all
outstanding equity-based compensation awards, other than stock options and/or stock appreciation rights, that are intended to
constitute performance-based compensation under Section 162(m)(4)(C) of the Code shall remain outstanding and shall vest or be
forfeited in accordance with the terms of the applicable award agreements, if the applicable performance goals are satisfied.

 

		5.3	Death or Disability.

 

		(a)	The
Executive’s employment hereunder shall terminate automatically upon the Executive’s death during the Employment Term,
and the Company may terminate the Executive’s employment on account of the Executive’s Disability.

 

		(b)	If
the Executive’s employment is terminated during the Employment Term on account of the Executive’s death or Disability,
the Executive (or the Executive’s estate and/or beneficiaries, as the case may be) shall be entitled to receive the following:

 

		(i)	the
Accrued Amounts; and

 

		(ii)	a
lump sum payment equal to the Pro-Rata Bonus/Annual Bonus, if any, that the Executive would have earned for the fiscal year in
which the Termination Date occurs based on the achievement of applicable performance goals for such year, which shall be payable
on the date that annual bonuses are paid to the Company’s similarly situated executives, but in no event later than two-and-a-half
(2 1/2) months following the end of the fiscal year in which the Termination Date occurs.

 

Notwithstanding any other provision contained
herein, all payments made in connection with the Executive’s Disability shall be provided in a manner which is consistent
with federal and state law.

 

		(c)	For purposes of this Agreement, “Disability”
shall mean the Executive’s inability, due to physical or mental incapacity, to perform the essential functions of his job,
with or without reasonable accommodation, for one hundred eighty (180) days out of any three hundred sixty-five (365) day period,
or one hundred twenty (120) consecutive days; provided however, in the event that the Company temporarily replaces the Executive,
or transfers the Executive’s duties or responsibilities to another individual on account of the Executive’s inability
to perform such duties due to a mental or physical incapacity which is, or is reasonably expected to become, a Disability, then
the Executive’s employment shall not be deemed terminated by the Company, and the Executive shall not be able to resign
with Good Reason as a result thereof.

 

Any question as to the existence of the
Executive’s Disability as to which the Executive and the Company cannot agree shall be determined in writing by a qualified
independent physician mutually acceptable to the Executive and the Company. If the Executive and the Company cannot agree as to
a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third who shall
make such determination in writing. The determination of Disability made in writing to the Company and the Executive shall be final
and conclusive for all purposes of this Agreement.

 

    7

     

    

  

		5.4	Change in Control Termination.

 

		(a)	Notwithstanding any other provision contained herein,
if the Executive’s employment hereunder is terminated by the Executive for Good Reason or by the Company on account of its
failure to renew the Agreement in accordance with Sections 1 and 5, or without Cause (other than on account of the Executive’s
death or Disability), in each case within twenty-four (24) months following a Change in Control, the Executive shall be entitled
to receive the Accrued Amounts and, subject to the Executive’s compliance with Section 6, Section 7, Section 8 and Section
9 of this Agreement, and his execution of a Release which becomes effective within thirty (30) days following the Termination
Date, the Executive shall be entitled to receive the following:

 

		(i)	a
lump sum payment equal to two (2) times the sum of the Executive’s Base Salary and Target Bonus for the year in which the
Termination Date occurs (or if greater, the year immediately preceding the year in which the Change in Control occurs), which
shall be paid within thirty (30) days following the Termination Date: provided that, if the Release Execution Period begins in
one taxable year and ends in another taxable year, payment shall not be made until the beginning of the second taxable year; and,

 

		(ii)	a
lump sum payment equal to the Executive’s Target Bonus for the fiscal year in which the Termination Date (as determined
in accordance with Section 5.6) occurs (or if greater, the year in which the Change in Control occurs), which shall be paid within
thirty (30) days following the Termination Date; provided that, if the Release Execution Period begins in one taxable year and
ends in another taxable year, payment shall not be made until the beginning of the second taxable year.

 

		(b)	Notwithstanding the terms of any equity incentive plan
or award agreements, as applicable:

 

		(i)	all
outstanding unvested stock options or stock appreciation rights granted to the Executive during the Employment Term shall become
fully vested and exercisable for the remainder of their full term;

 

		(ii)	all
outstanding equity-based compensation awards other than stock options or stock appreciation rights that are not intended to qualify
as performance-based compensation under Section 162(m)(4)(C) of the Code shall become fully vested and the restrictions thereon
shall lapse; provided that, any delays in the settlement or payment of such awards that are set forth in the applicable award
agreement and that are required under Section 409A shall remain in effect; and,

 

		(iii)	all
outstanding equity-based compensation awards other than stock options and stock appreciation rights that are intended to constitute
performance-based compensation under Section 162(m)(4)(C) of the Code shall remain outstanding and shall vest or be forfeited
in accordance with the terms of the applicable award agreements, if the applicable performance goals are satisfied.

 

		(c)	For purposes of this Agreement, “Change in Control”
shall mean the occurrence of any of the following after the Effective Date:

 

		(i)	one
person (or more than one person acting as a group) acquires ownership of stock of the Company that, together with the stock
held by such person or group, constitutes more than fifty (50%) of the total fair market value or total voting power of the stock
of such corporation; provided that, a Change in Control shall not occur if any person (or more than one person acting as a group)
owns more than fifty (50%) of the total fair market value or total voting power of the Company’s stock and acquires additional
stock;

 

		(ii)	a
majority of the members of the Board are replaced during any twelve-month period by directors whose appointment or election is
not endorsed by a majority of the Board before the date of appointment or election; or

 

    8

     

    

  

		(iii)	the
sale of all or substantially all of the Company’s assets.

 

Notwithstanding the foregoing, a Change
in Control shall not occur unless such transaction constitutes a change in the ownership of the Company, a change in effective
control of the Company, or a change in the ownership of a substantial portion of the Company’s assets under Section 409A.

 

		5.5	Notice of Termination. Any termination of the Executive’s
employment hereunder by the Company or by the Executive during the Employment Term (other than termination pursuant to Section
5.3(a) on account of the Executive’s death) shall be communicated by written notice of termination (“Notice of Termination”)
to the other party hereto in accordance with Section 27.

 

The Notice of Termination shall specify:

 

		(a)	The
termination provision of this Agreement relied upon;

 

		(b)	To
the extent applicable, the facts and circumstances claimed to provide a basis for termination of the Executive’s employment
under the provision so indicated; and

 

		(c)	The
applicable Termination Date.

 

		5.6	Termination Date. The Executive’s “Termination
Date” shall be:

 

		(a)	If
the Executive’s employment hereunder terminates on account of the Executive’s death, the date of the Executive’s
death;

 

		(b)	If
the Executive’s employment hereunder is terminated on account of the Executive’s Disability, the date that it is determined
that the Executive has a Disability;

 

		(c)	If
the Company terminates the Executive’s employment hereunder for Cause, the date the Notice of Termination is delivered to
the Executive;

 

		(d)	If
the Company terminates the Executive’s employment hereunder without Cause, the date specified in the Notice of Termination,
which shall be no less than thirty (30) days following the date on which the Notice of Termination is delivered; provided that,
the Company shall have the option to provide the Executive with a lump sum payment equal to thirty (30) days’ Base Salary
in lieu of such notice, which shall be paid in a lump sum on the Executive’s Termination Date and for all purposes of this
Agreement, the Executive’s Termination Date shall be the date on which such Notice of Termination is delivered;

 

		(e)	If
the Executive terminates his employment hereunder with or without Good Reason, the date specified in the Executive’s Notice
of Termination, which shall be no less than thirty (30) days following the date on which the Notice of Termination is delivered;
[provided that, the Company may waive all or any part of the thirty (30) day notice period for no consideration by giving written
notice to the Executive and for all purposes of this Agreement, the Executive’s Termination Date shall be the date determined
by the Company]; and

 

		(f)	If
the Executive’s employment hereunder terminates because either party provides notice of non- renewal pursuant to Section
1, the Renewal Date immediately following the date on which the applicable party delivers notice of non-renewal.

 

    9

     

    

  

Notwithstanding anything contained herein,
the Termination Date shall not occur until the date on which the Executive incurs a “separation from service” within
the meaning of Section 409A.

 

		5.7	Mitigation.
In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts
payable to the Executive under any of the provisions of this Agreement and except as provided in Section 5.2(c), any amounts payable
pursuant to this Section 5 shall not be reduced by compensation the Executive earns on account of employment with another employer].

 

		5.8	Resignation
of All Other Positions. Upon termination of the Executive’s employment hereunder for any reason, the Executive agrees to
resign, effective on the Termination Date, shall be deemed to have resigned from all positions that the Executive holds as an
officer or member of the Board (or a committee thereof) of the Company or any of its affiliates.

 

		5.9	Section
280G.

 

		(a)	If
any of the payments or benefits received or to be received by the Executive (including, without limitation, any payment or benefits
received in connection with a Change in Control or the Executive’s termination of employment, whether pursuant to the terms
of this Agreement or any other plan, arrangement, or agreement, or otherwise) (all such payments collectively referred to herein
as the “280G Payments”) constitute “parachute payments” within the meaning of Section 280G of the Code
and will be subject to the excise tax imposed under Section 4999 of the Code (the “Excise Tax”), the Company shall
pay to the Executive, no later than the time such Excise Tax is required to be paid by the Executive or withheld by the Company,
an additional amount equal to the sum of the Excise Tax payable by the Executive, plus the amount necessary to put the Executive
in the same after-tax position (taking into account any and all applicable federal, state, and local excise, income, or other
taxes at the highest applicable rates on such 280G Payments and on any payments under this Section 5.9 or otherwise) as if no
Excise Tax had been imposed.

 

		(b)	All
calculations and determinations under this Section 5.9 shall be made by an independent accounting firm or independent tax counsel
appointed by the Company (the “Tax Counsel”) whose determinations shall be conclusive and binding on the Company and
the Executive for all purposes. For purposes of making the calculations and determinations required by this Section 5.9, the Tax
Counsel may rely on reasonable, good faith assumptions and approximations concerning the application of Section 280G and Section
4999 of the Code. The Company and the Executive shall furnish the Tax Counsel with such information and documents as the Tax Counsel
may reasonably request in order to make its determinations under this Section 5.9. The Company shall bear all costs the Tax Counsel
may reasonably incur in connection with its services.

 

		6.	Cooperation.
The parties agree that certain matters in which the Executive will be involved during the Employment Term may necessitate the
Executive’s cooperation in the future. Accordingly, following the termination of the Executive’s employment for any
reason, to the extent reasonably requested by the Board, the Executive shall cooperate with the Company in connection with matters
arising out of the Executive’s service to the Company; provided that, the Company shall make reasonable efforts to minimize
disruption of the Executive’s other activities. The Company shall reimburse the Executive for reasonable expenses incurred
in connection with such cooperation and, to the extent that the Executive is required to spend substantial time on such matters,
the Company shall compensate the Executive at an hourly rate based on the Executive’s Base Salary on the Termination Date.

 

		7.	Confidential
Information. The Executive understands and acknowledges that during the Employment Term, he will have access to and learn about
Confidential Information, as defined below.

 

    10

     

    

  

		7.1	Confidential Information Defined. (a) Definition.

 

For purposes of this Agreement, “Confidential
Information” includes, but is not limited to, all information not generally known to the public, in spoken, printed, electronic
or any other form or medium, relating directly or indirectly to: business processes, practices, methods, policies, plans, publications,
documents, research, operations, services, strategies, techniques, agreements, contracts, terms of agreements, transactions, potential
transactions, negotiations, pending negotiations, know-how, trade secrets, web design, work-in-process, databases, manuals, records,
articles, systems, material, sources of material, supplier information, vendor information, financial information, results, accounting
information, accounting records, legal information, marketing information, advertising information, pricing information, credit
information, design information, payroll information, staffing information, personnel information, employee lists, supplier lists,
vendor lists, developments, reports, internal controls, security procedures, graphics, drawings, sketches, market studies, sales
information, revenue, costs, formulae, notes, communications, product plans, designs, styles, models, ideas, audiovisual programs,
inventions, unpublished patent applications, original works of authorship, discoveries, experimental processes, experimental results,
specifications, customer information, customer lists, client information, client lists, manufacturing information, factory lists,
distributor lists, and buyer lists of the Company or its businesses or any existing or prospective customer, supplier, investor
or other associated third party, or of any other person or entity that has entrusted information to the Company in confidence.

 

The Executive understands that the
above list is not exhaustive, and that Confidential Information also includes other information that is marked or otherwise
identified as confidential or proprietary, or that would otherwise appear to a reasonable person to be confidential or
proprietary in the context and circumstances in which the information is known or used.

 

The Executive understands and agrees that
Confidential Information includes information developed by him in the course of his employment by the Company as if the Company
furnished the same Confidential Information to the Executive in the first instance. Confidential Information shall not include
information that is generally available to and known by the public at the time of disclosure to the Executive; provided that, such
disclosure is through no direct or indirect fault of the Executive or person(s) acting on the Executive’s behalf.

 

		(b)	Company
Creation and Use of Confidential Information.

 

The Executive understands and acknowledges
that the Company has invested, and continues to invest, substantial time, money, and specialized knowledge into developing its
resources, creating a customer base, generating customer and potential customer lists, training its employees, and improving its
offerings in the field of Cannabis Consulting and Company proprietary products and processes. The Executive understands and acknowledges
that as a result of these efforts, the Company has created, and continues to use and create Confidential Information. This Confidential
Information provides the Company with a competitive advantage over others in the marketplace.

 

    11

     

    

  

		(c)	Disclosure
and Use Restrictions.

 

The Executive agrees and covenants: (i)
to treat all Confidential Information as strictly confidential; (ii) not to directly or indirectly disclose, publish, communicate,
or make available Confidential Information, or allow it to be disclosed, published, communicated, or made available, in whole or
part, to any entity or person whatsoever (including other employees of the Company) not having a need to know and authority to
know and use the Confidential Information in connection with the business of the Company and, in any event, not to anyone outside
of the direct employ of the Company except as required in the performance of the Executive’s authorized employment duties
to the Company or with the prior consent of the Board of Directors acting on behalf of the Company in each instance (and then,
such disclosure shall be made only within the limits and to the extent of such duties or consent); and (iii) not to access or use
any Confidential Information, and not to copy any documents, records, files, media, or other resources containing any Confidential
Information, or remove any such documents, records, files, media, or other resources from the premises or control of the Company,
except as required in the performance of the Executive’s authorized employment duties to the Company or with the prior consent
of The Board of Directors acting on behalf of the Company in each instance (and then, such disclosure shall be made only within
the limits and to the extent of such duties or consent). Nothing herein shall be construed to prevent disclosure of Confidential
Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction
or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law,
regulation, or order. The Executive shall promptly provide written notice of any such order to The Board of Directors.

 

		(d)	Notice
of Immunity Under the Economic Espionage Act of 1996, as amended by the Defend Trade Secrets Act of 2016 (“DTSA”).
Notwithstanding any other provision of this Agreement:

 

		(i)	The Executive will not be held criminally or civilly
liable under any federal or state trade secret law for any disclosure of a trade secret that:

 

		(A)	is
made (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and
(2) solely for the purpose of reporting or investigating a suspected violation of law; or

 

		(B)	is
made in a complaint or other document filed under seal in a lawsuit or other proceeding.

 

		(ii)	If the Executive files a lawsuit for retaliation by
the Company for reporting a suspected violation of law, the Executive may disclose the Company’s trade secrets to the Executive’s
attorney and use the trade secret information in the court proceeding if the Executive:

 

		(A)	files any document containing trade secrets under
seal; and (B) does not disclose trade secrets, except pursuant to court order.

 

		8.	Restrictive
Covenants.

 

		8.1	Acknowledgement.
The Executive understands that the nature of the Executive’s position gives him access to and knowledge of Confidential
Information and places him in a position of trust and confidence with the Company. The Executive understands and acknowledges
that the intellectual or artistic or other services he provides to the Company are unique, special, or extraordinary.

 

    12

     

    

  

The Executive further understands and acknowledges
that the Company’s ability to reserve these for the exclusive knowledge and use of the Company is of great competitive importance
and commercial value to the Company, and that improper use or disclosure by the Executive is likely to result in unfair or unlawful
competitive activity.

 

		8.2	Non-Competition.
Because of the Company’s legitimate business interest as described herein and the good and valuable consideration offered
to the Executive, during the Employment Term and for twelve (12) months beginning on the last day of the Executive’s employment
with the Company, for any reason or no reason, and whether employment is terminated at the option of the Executive or the Company,
the Executive agrees and covenants not to engage in Prohibited Activity.

 

For purposes of this Section 8, “Prohibited
Activity” is activity in which the Executive contributes his knowledge, directly or indirectly, in whole or in part, as an
employee, employer, owner, operator, manager, advisor, consultant, agent, employee, partner, director, stockholder, officer, volunteer,
intern, or any other similar capacity to an entity engaged in the same or similar business as the Company, including those engaged
in the business of Cannabis Consulting and like Company proprietary products and processes. Prohibited Activity also includes activity
that may require or inevitably requires disclosure of trade secrets, proprietary information or Confidential Information.

 

Nothing herein shall prohibit the Executive
from purchasing or owning less than five percent (5%) of the publicly traded securities of any corporation, provided that such
ownership represents a passive investment and that the Executive is not a controlling person of, or a member of a group that controls,
such corporation.

 

This Section 8 does not, in any way, restrict
or impede the Executive from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying
with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency,
provided that such compliance does not exceed that required by the law, regulation, or order. The Executive shall promptly provide
written notice of any such order to The Board of Directors.

 

		8.3	Non-Solicitation
of Employees. The Executive agrees and covenants not to directly or indirectly solicit, hire, recruit, attempt to hire or recruit,
or induce the termination of employment of any employee of the Company during twelve (12) months, beginning on the last day of
the Executive’s employment with the Company.

 

		8.4	Non-Solicitation
of Customers. The Executive understands and acknowledges that because of the Executive’s experience with and relationship
to the Company, he will have access to and learn about much or all of the Company’s customer information. “Customer
Information” includes, but is not limited to, names, phone numbers, addresses, e-mail addresses, order history, order preferences,
chain of command, pricing information, and other information identifying facts and circumstances specific to the customer and
relevant to sales or services.

 

    13

     

    

  

The Executive understands and acknowledges
that loss of this customer relationship and/or goodwill will cause significant and irreparable harm.

 

The Executive agrees and covenants, during
twelve (12) months, beginning on the last day of the Executive’s employment with the Company, not to directly or indirectly
solicit, contact (including but not limited to e-mail, regular mail, express mail, telephone, fax, and instant message), attempt
to contact, or meet with the Company’s current, former or prospective customers for purposes of offering or accepting goods
or services similar to or competitive with those offered by the Company.

 

This restriction shall only apply to:

 

		(a)	Customers
or prospective customers the Executive contacted in any way during the past twelve (12) months;

 

		(b)	Customers
about whom the Executive has trade secret or confidential information; (c) Customers who became customers during the Executive’s
employment with the Company; and (d) Customers about whom the Executive has information that is not available publicly.

 

		9.	Non-Disparagement.
The Executive agrees and covenants that he will not at any time make, publish or communicate to any person or entity or in any
public forum any defamatory or disparaging remarks, comments, or statements concerning the Company or its businesses, or any of
its employees, officers, and existing and prospective customers, suppliers, investors and other associated third parties.

 

This Section 9 does not, in any way, restrict
or impede the Executive from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying
with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency,
provided that such compliance does not exceed that required by the law, regulation, or order. The Executive shall promptly provide
written notice of any such order to The Board of Directors.

 

The Company agrees and covenants that it
shall cause its officers and directors to refrain from making any defamatory or disparaging remarks, comments, or statements concerning
the Executive to any third parties.

 

		10.	Acknowledgement.
The Executive acknowledges and agrees that the services to be rendered by him to the Company are of a special and unique character;
that the Executive will obtain knowledge and skill relevant to the Company’s industry, methods of doing business and marketing
strategies by virtue of the Executive’s employment; and that the restrictive covenants and other terms and conditions of
this Agreement are reasonable and reasonably necessary to protect the legitimate business interest of the Company.

 

The Executive further acknowledges that
the amount of his compensation reflects, in part, his obligations and the Company’s rights under Section 7, Section 8, and
Section 9 of this Agreement; that he has no expectation of any additional compensation, royalties or other payment of any kind
not otherwise referenced herein in connection herewith; and that he will not be subject to undue hardship by reason of his full
compliance with the terms and conditions of Section 7, Section 8, and Section 9 of this Agreement or the Company’s enforcement
thereof.

 

    14

     

    

  

		11.	Remedies. In the event of a breach or threatened breach
by the Executive of Section 7, Section 8, or Section 9 of this Agreement, the Executive hereby consents and agrees that the Company
shall be entitled to seek, in addition to other available remedies, a temporary or permanent injunction or other equitable relief
against such breach or threatened breach from any court of competent jurisdiction, without the necessity of showing any actual
damages or that money damages would not afford an adequate remedy, and without the necessity of posting any bond or other security.
The aforementioned equitable relief shall be in addition to, not in lieu of, legal remedies, monetary damages, or other available
forms of relief. In the event the Company seeks and obtains legal and/or equitable relief under this Section, the Company shall
recover its attorney fees and costs from Executive.

 

    15

     

    

  

		12.	Arbitration.
Any dispute, controversy or claim arising out of or related to this Agreement or any breach of this Agreement shall be submitted
to and decided by binding arbitration. Arbitration shall be administered exclusively by the American Arbitration Association and
shall be conducted consistent with the rules, regulations, and requirements thereof as well as any requirements imposed by state
law. Any arbitral award determination shall be final and binding upon the parties. The prevailing party in any binding arbitration
may recover its reasonable attorney fees as an element of costs, subject to the discretion of the arbitrator or arbitrators.

 

		13.	Proprietary
Rights.

 

		13.1	Work
Product. The Executive acknowledges and agrees that all right, title, and interest in and to all writings, works of authorship,
technology, inventions, discoveries, processes, techniques, methods, ideas, concepts, research, proposals, materials, and all
other work product of any nature whatsoever, that are created, prepared, produced, authored, edited, amended, conceived, or reduced
to practice by the Executive individually or jointly with others during the period of his employment by the Company and relate
in any way to the business or contemplated business, products, activities, research, or development of the Company or result from
any work performed by the Executive for the Company (in each case, regardless of when or where prepared or whose equipment or
other resources is used in preparing the same), all rights and claims related to the foregoing, and all printed, physical and
electronic copies, and other tangible embodiments thereof (collectively, “Work Product”), as well as any and all rights
in and to US and foreign (a) patents, patent disclosures and inventions (whether patentable or not), (b) trademarks, service marks,
trade dress, trade names, logos, corporate names, and domain names, and other similar designations of source or origin, together
with the goodwill symbolized by any of the foregoing, (c) copyrights and copyrightable works (including computer programs), mask
works, and rights in data and databases, (d) trade secrets, know-how, and other confidential information, and (e) all other intellectual
property rights, in each case whether registered or unregistered and including all registrations and applications for, and renewals
and extensions of, such rights, all improvements thereto and all similar or equivalent rights or forms of protection in any part
of the world (collectively, “Intellectual Property Rights”), shall be the sole and exclusive property of the Company.

 

For purposes of this Agreement, Work Product
includes, but is not limited to, Company Group information, including plans, publications, research, strategies, techniques, agreements,
documents, contracts, terms of agreements, negotiations, know-how, computer programs, computer applications, software design, web
design, work in process, databases, manuals, results, developments, reports, graphics, drawings, sketches, market studies, formulae,
notes, communications, algorithms, product plans, product designs, styles, models, audiovisual programs, inventions, unpublished
patent applications, original works of authorship, discoveries, experimental processes, experimental results, specifications, customer
information, client information, customer lists, client lists, manufacturing information, marketing information, advertising information,
and sales information.

 

    16

     

    

  

		13.2	Work
Made for Hire; Assignment. The Executive acknowledges that, by reason of being employed by the Company at the relevant times,
to the extent permitted by law, all of the Work Product consisting of copyrightable subject matter is “work made for hire”
as defined in 17 U.S.C. § 101 and such copyrights are therefore owned by the Company. To the extent that the foregoing does
not apply, the Executive hereby irrevocably assigns to the Company, for no additional consideration, the Executive’s entire
right, title, and interest in and to all Work Product and Intellectual Property Rights therein, including the right to sue, counterclaim,
and recover for all past, present, and future infringement, misappropriation, or dilution thereof, and all rights corresponding
thereto throughout the world. Nothing contained in this Agreement shall be construed to reduce or limit the Company’s rights,
title, or interest in any Work Product or Intellectual Property Rights so as to be less in any respect than that the Company would
have had in the absence of this Agreement.

 

		13.3	Further Assurances; Power of Attorney. During and
after his employment, the Executive agrees to reasonably cooperate with the Company to (a) apply for, obtain, perfect, and transfer
to the Company the Work Product as well as any and all Intellectual Property Rights in the Work Product in any jurisdiction in
the world; and (b) maintain, protect and enforce the same, including, without limitation, giving testimony and executing and delivering
to the Company any and all applications, oaths, declarations, affidavits, waivers, assignments, and other documents and instruments
as shall be requested by the Company. The Executive hereby irrevocably grants the Company power of attorney to execute and deliver
any such documents on the Executive’s behalf in his name and to do all other lawfully permitted acts to transfer the Work
Product to the Company and further the transfer, prosecution, issuance, and maintenance of all Intellectual Property Rights therein,
to the full extent permitted by law, if the Executive does not promptly cooperate with the Company’s request (without limiting
the rights the Company shall have in such circumstances by operation of law). The power of attorney is coupled with an interest
and shall not be affected by the Executive’s subsequent incapacity.

 

		13.4	No
License. The Executive understands that this Agreement does not, and shall not be construed to, grant the Executive any license
or right of any nature with respect to any Work Product or Intellectual Property Rights or any Confidential Information, materials,
software, or other tools made available to him by the Company.

 

		14.	Security.

 

		14.1	Security and Access. The Executive agrees and covenants
(a) to comply with all Company security policies and procedures as in force from time to time including without limitation those
regarding computer equipment, telephone systems, voicemail systems, facilities access, monitoring, key cards, access codes, Company
intranet, internet, social media and instant messaging systems, computer systems, e-mail systems, computer networks, document
storage systems, software, data security, encryption, firewalls, passwords and any and all other Company facilities, IT resources
and communication technologies (“Facilities and Information Technology Resources”); (b) not to access or use any Facilities
and Information Technology Resources except as authorized by the Company; and (iii) not to access or use any Facilities and Information
Technology Resources in any manner after the termination of the Executive’s employment by the Company, whether termination
is voluntary or involuntary. The Executive agrees to notify the Company promptly in the event he learns of any violation of the
foregoing by others, or of any other misappropriation or unauthorized access, use, reproduction, or reverse engineering of, or
tampering with any Facilities and Information Technology Resources or other Company property or materials by others.

 

    17

     

    

  

		14.2	Exit
Obligations. Upon (a) voluntary or involuntary termination of the Executive’s employment or (b) the Company’s request
at any time during the Executive’s employment, the Executive shall (i) provide or return to the Company any and all Company
property, including keys, key cards, access cards, identification cards, security devices, employer credit cards, network access
devices, computers, cell phones, smartphones, PDAs, pagers, fax machines, equipment, speakers, webcams, manuals, reports, files,
books, compilations, work product, e-mail messages, recordings, tapes, disks, thumb drives or other removable information storage
devices, hard drives, negatives and data and all Company documents and materials belonging to the Company and stored in any fashion,
including but not limited to those that constitute or contain any Confidential Information or Work Product, that are in the possession
or control of the Executive, whether they were provided to the Executive by the Company or any of its business associates or created
by the Executive in connection with his employment by the Company; and (ii) delete or destroy all copies of any such documents
and materials not returned to the Company that remain in the Executive’s possession or control, including those stored on
any non- Company devices, networks, storage locations, and media in the Executive’s possession or control.

 

		15.	Publicity.
The Executive hereby irrevocably consents to any and all uses and displays, by the Company and its agents, representatives and
licensees, of the Executive’s name, voice, likeness, image, appearance, and biographical information in, on or in connection
with any pictures, photographs, audio and video recordings, digital images, websites, television programs and advertising, other
advertising and publicity, sales and marketing brochures, books, magazines, other publications, CDs, DVDs, tapes, and all other
printed and electronic forms and media throughout the world, at any time during or after the period of his employment by the Company,
for all legitimate commercial and business purposes of the Company (“Permitted Uses”) without further consent from
or royalty, payment, or other compensation to the Executive. The Executive hereby forever waives and releases the Company and
its directors, officers, employees, and agents from any and all claims, actions, damages, losses, costs, expenses, and liability
of any kind, arising under any legal or equitable theory whatsoever at any time during or after the period of his employment by
the Company, arising directly or indirectly from the Company’s and its agents’, representatives’, and licensees’
exercise of their rights in connection with any Permitted Uses.

 

		16.	Governing
Law: Jurisdiction and Venue. This Agreement, for all purposes, shall be construed in accordance with the laws of California without
regard to conflicts of law principles. Any action or proceeding by either of the parties to enforce this Agreement shall be brought
only in a state or federal court located in the state of California county of Los Angeles. The parties hereby irrevocably submit
to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance of any such action
or proceeding in such venue.

 

		17.	Entire
Agreement. Unless specifically provided herein, this Agreement contains all of the understandings and representations between
the Executive and the Company pertaining to the subject matter hereof and supersedes all prior and contemporaneous understandings,
agreements, representations and warranties, both written and oral, with respect to such subject matter. The parties mutually agree
that the Agreement can be specifically enforced in court and can be cited as evidence in legal proceedings alleging breach of
the Agreement.

 

    18

     

    

  

		18.	Modification
and Waiver. No provision of this Agreement may be amended or modified unless such amendment or modification is agreed to in writing
and signed by the Executive and by The Board of Directors. No waiver by either of the parties of any breach by the other party
hereto of any condition or provision of this Agreement to be performed by the other party hereto shall be deemed a waiver of any
similar or dissimilar provision or condition at the same or any prior or subsequent time, nor shall the failure of or delay by
either of the parties in exercising any right, power, or privilege hereunder operate as a waiver thereof to preclude any other
or further exercise thereof or the exercise of any other such right, power, or privilege.

 

		19.	Severability.
Should any provision of this Agreement be held by a court of competent jurisdiction to be enforceable only if modified, or if
any portion of this Agreement shall be held as unenforceable and thus stricken, such holding shall not affect the validity of
the remainder of this Agreement, the balance of which shall continue to be binding upon the parties with any such modification
to become a part hereof and treated as though originally set forth in this Agreement.

 

The parties further agree that any such
court is expressly authorized to modify any such unenforceable provision of this Agreement in lieu of severing such unenforceable
provision from this Agreement in its entirety, whether by rewriting the offending provision, deleting any or all of the offending
provision, adding additional language to this Agreement, or by making such other modifications as it deems warranted to carry out
the intent and agreement of the parties as embodied herein to the maximum extent permitted by law.

 

The parties expressly agree that this Agreement
as so modified by the court shall be binding upon and enforceable against each of them. In any event, should one or more of the
provisions of this Agreement be held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability
shall not affect any other provisions hereof, and if such provision or provisions are not modified as provided above, this Agreement
shall be construed as if such invalid, illegal, or unenforceable provisions had not been set forth herein.

 

		20.	Captions.
Captions and headings of the sections and paragraphs of this Agreement are intended solely for convenience and no provision of
this Agreement is to be construed by reference to the caption or heading of any section or paragraph.

 

		21.	Counterparts.
This Agreement may be executed in separate counterparts, each of which shall be deemed an original, but all of which taken together
shall constitute one and the same instrument.

 

		22.	Tolling.
Should the Executive violate any of the terms of the restrictive covenant obligations articulated herein, the obligation at issue
will run from the first date on which the Executive ceases to be in violation of such obligation.

 

    19

     

    

 

		23.	Section
409A.

 

		23.1	General
Compliance. This Agreement is intended to comply with Section 409A or an exemption thereunder and shall be construed and administered
in accordance with Section 409A. Notwithstanding any other provision of this Agreement, payments provided under this Agreement
may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. Any payments under
this Agreement that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or
as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each
installment payment provided under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement
upon a termination of employment shall only be made upon a “separation from service” under Section 409A. Notwithstanding
the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section
409A, and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest, or other expenses
that may be incurred by the Executive on account of non-compliance with Section 409A.

 

		23.2	Specified
Employees. Notwithstanding any other provision of this Agreement, if any payment or benefit provided to the Executive in connection
with his termination of employment is determined to constitute “nonqualified deferred compensation” within the meaning
of Section 409A and the Executive is determined to be a “specified employee” as defined in Section 409A(a)(2)(b)(i),
then such payment or benefit shall not be paid until the first payroll date to occur following the six-month anniversary of the
Termination Date or, if earlier, on the Executive’s death (the “Specified Employee Payment Date”). The aggregate
of any payments that would otherwise have been paid before the Specified Employee Payment Date, and interest on such amounts calculated
based on the applicable federal rate published by the Internal Revenue Service for the month in which the Executive’s separation
from service occurs, shall be paid to the Executive in a lump sum on the Specified Employee Payment Date and thereafter, any remaining
payments shall be paid without delay in accordance with their original schedule.

 

		23.3	Reimbursements.
To the extent required by Section 409A, each reimbursement or in-kind benefit provided under this Agreement shall be provided
in accordance with the following:

 

		(a)	the
amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses
eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year;

 

		(b)	any
reimbursement of an eligible expense shall be paid to the Executive on or before the last day of the calendar year following the
calendar year in which the expense was incurred; and

 

		(c)	any
right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.

 

		23.4	Tax Gross-ups. Any tax gross-up payments provided
under this Agreement shall be paid to the Executive on or before December 31 of the calendar year immediately following the calendar
year in which the Executive remits the related taxes.

 

		24.	Notification
to Subsequent Employer. When the Executive’s employment with the Company terminates, the Executive agrees to notify any
subsequent employer of the restrictive covenants sections contained in this Agreement. The Executive will also deliver a copy
of such notice to the Company before the Executive commences employment with any subsequent employer. In addition, the Executive
authorizes the Company to provide a copy of the restrictive covenants sections of this Agreement to third parties, including but
not limited to, the Executive’s subsequent, anticipated, or possible future employer.

 

    20

     

    

  

		25.	Successors
and Assigns. This Agreement is personal to the Executive and shall not be assigned by the Executive. Any purported assignment
by the Executive shall be null and void from the initial date of the purported assignment. The Company may assign this Agreement
to any successor or assign (whether direct or indirect, by purchase, merger, consolidation, or otherwise) to all or substantially
all of the business or assets of the Company. This Agreement shall inure to the benefit of the Company and permitted successors
and assigns.

 

		26.	Notice.
Notices and all other communications provided for in this Agreement shall be in writing and shall be delivered personally or sent
by registered or certified mail, return receipt requested, or by overnight carriers to the parties at the addresses set forth:

 

MCTC Holdings

520 S Grand Ave #320

Los Angeles, Ca 90071

 

Arman Tabatabaei

14252 Culver Dr #A555

Irvine, Ca 92604

 

		27.	Representations
of the Executive. The Executive represents and warrants to the company that:

 

The Executive’s acceptance of employment
with the Company and the performance of his duties hereunder will not conflict with or result in a violation of, a breach of, or
a default under any contract, agreement, or understanding to which he is a party or is otherwise bound.

 

The Executive’s acceptance of employment
with the Company and the performance of his duties hereunder will not violate any non-solicitation, non-competition, or other similar
covenant or agreement of a prior employer.

 

		28.	Survival.
Upon the expiration or other termination of this Agreement, the respective rights and obligations of the parties hereto shall
survive such expiration or other termination to the extent necessary to carry out the intentions of the parties under this Agreement.

 

		29.	Acknowledgement of Full Understanding. THE EXECUTIVE ACKNOWLEDGES
AND AGREES THAT HE HAS FULLY READ, UNDERSTANDS AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. THE EXECUTIVE ACKNOWLEDGES AND AGREES
THAT HE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF HIS CHOICE BEFORE SIGNING THIS AGREEMENT.

 

    21

     

    

  

IN WITNESS WHEREOF, the parties hereto
have executed this Agreement as of the date first above written.

 

	MCTC Holdings Inc:	 
	 	 
	/s/ Arman Tabatabaei	 
	Arman Tabatabaei	 
	Chief Executive Officer and Chairman	 
	 	 
	/s/ Robert Hymers	 
	Robert Hymers	 
	Director	 

 

 

22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]